Massimo Breccia, Elisabetta Abruzzese, Alessandra Iurlo, Antonella Gozzini, Alessandro Isidori, Domenica Gangemi, Patrizia Pregno, and Giuliana Alimena. 2016. “Efficacy and Safety of Second-Line Ponatinib After Failure of a Single Previous Tyrosine Kinase Inhibitor for Chronic Myeloid Leukemia Patients in Chronic Phase”. Haematologica 101 (6). Pavia, Italy, e267-e268. https://doi.org/10.3324/haematol.2016.145623.